In his return to the White House this week, President Donald Trump issued a flurry of executive orders on immigration, including declaring an emergency at the U.S.-Mexico border, suspending refugee admissions, and calling to roll back birthright citizenship. His administration rescinded a long-standing policy not to arrest people without legal status at or near sensitive…
The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ever-busy and demanding lives of patients, families, and caregivers. The post Extending ADHD Coverage for the Entire Active Day appeared first on MedCity News.
GoodRx launched GoodRx Employer Direct, a program that allows employers to subsidize manufacturer-sponsored prices for high-cost brand medications like GLP-1s without adding them to their health insurance benefits. The post GoodRx Launches Employer Program to Help Subsidize High-Cost Brand Drugs appeared first on MedCity News.
The application of AI technology is part of a carefully orchestrated effort dependent on human intelligence, and the collaboration of physicians, disease-specific specialists, nurses, data scientists, and technologists. Done right, these efforts can lead to profound benefits, and offer a promising future for clinical research and patient care. The post Augmenting Brain Power: Real-World Data, Advanced…
A large study from Massachusetts has found that babies whose mothers had covid-19 while pregnant were slightly more likely to have a range of neurodevelopmental diagnoses by age 3. Most of these children had speech or motor delays, and the link was strongest in boys and when the mother was infected late in pregnancy. The…
This analysis presents findings from the 2026 KFF Women’s Health Survey on women’s reported need for and use of fertility services.
Colton George, un niño de 9 años, de Indiana, se sintió enfermo. Les dijo a sus padres que le dolía el estómago. No paraba de correr al baño y se sentía demasiado mal como para terminar un partido de baloncesto. Días más tarde, estaba en una cama de hospital, luchando por su vida. La demanda…
A paper by Proudman et al. (2024) finds that doing so would be extremely expensive. Including all preclinical, clinical and post-approval R&D activities, total annual costs to maintain the average lifecycle level of 49.4 approved drugs across all disease areas during the 2018–22 period was estimated to be $139.6 billion. Including only pre-launch costs, total…
The 2025 reconciliation law includes new eligibility restrictions for many lawfully present immigrants for Medicaid and CHIP that become effective October 1, 2026. This brief provides an overview of implementation of the immigrant eligibility changes based on CMS guidance and issues to consider for affected individuals and states.
This KFF brief provides key facts about U.S. funding for global health, including the range of efforts the U.S. supports, U.S. agencies/departments involved in global health activities, funding trends, and more.